Sotera Health (SHC)
(Real Time Quote from BATS)
$14.09 USD
+0.87 (6.58%)
Updated Aug 5, 2024 02:16 PM ET
2-Buy of 5 2
B Value B Growth B Momentum B VGM
Sotera Health Company (SHC) Price Targets
Average Price Target | Highest Price Target | Lowest Price Target | Upside to Average Price Target |
---|---|---|---|
$14.42 | $17.00 | $12.00 | 9.08% |
Price Target
Based on short-term price targets offered by six analysts, the average price target for Sotera Health Company comes to $14.42. The forecasts range from a low of $12.00 to a high of $17.00. The average price target represents an increase of 9.08% from the last closing price of $13.22.
Analyst Price Targets (6 )
Broker Rating
Sotera Health Company currently has an average brokerage recommendation (ABR) of 2.00 on a scale of 1 to 5 (Strong Buy to Strong Sell), calculated based on the actual recommendations (Buy, Hold, Sell etc.) made by seven brokerage firms. The current ABR compares to an ABR of 2.00 a month ago based on seven recommendations.
Of the seven recommendations deriving the current ABR, three are Strong Buy and one is Buy. Strong Buy and Buy respectively account for 42.86% and 14.29% of all recommendations. A month ago, Strong Buy made up 42.86%, while Buy represented 14.29%.
Broker Rating Breakdown
Brokerage Recommendations
Today | 1 Week Ago | 1 Month Ago | 2 Months Ago | 3 Months Ago | |
---|---|---|---|---|---|
Strong Buy | 3 | 3 | 3 | 3 | 3 |
Buy | 1 | 1 | 1 | 1 | 1 |
Hold | 3 | 3 | 3 | 3 | 2 |
Sell | 0 | 0 | 0 | 0 | 0 |
Strong Sell | 0 | 0 | 0 | 0 | 0 |
ABR | 2.00 | 2.00 | 2.00 | 2.00 | 1.83 |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Analyst Upgrades/Downgrades
Date | Brokerage Firm | Analyst | Previous | Current |
---|---|---|---|---|
7/30/2024 | Not Identified | Not Identified | Moderate Buy | Moderate Buy |
5/21/2024 | Piper Sandler | Jason Bednar | Not Available | Hold |
4/10/2024 | Not Identified | Not Identified | Strong Buy | Strong Buy |
4/3/2024 | Not Identified | Not Identified | Hold | Strong Buy |
3/25/2024 | Not Identified | Not Identified | Hold | Strong Buy |
2/6/2024 | KeyBanc Capital Markets | Brett Fishbin | Hold | Hold |
1. Not Ident. Many of the brokerage firms who provide Zacks data ask that we keep their identity confidential.
2. In most cases the # of brokers listed above is less than the # of brokerage firms that have a recommendation on the stock. That is because some firms prohibit Zacks from displaying detailed information on their recommendations such as in the upgrade/downgrade table.
Average Brokerage Rating
Current ABR | 2.00 |
ABR (Last week) | 2.00 |
# of Recs in ABR | 7 |
Average Target Price | $14.42 |
LT Growth Rate | NA |
Industry | Medical Services |
Industry Rank by ABR | 103 of 253 |
Current Quarter EPS Est: | 0.17 |